Stylianos Kakolyris
Alexandroupoli, ESYE11 68100, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 63 publications
Νovel methylation biomarkers in liquid biopsy and classifying biosignatures for the clinical management of breast cancer.
Journal: Breast cancer research : BCR
Published: May 19, 2025
Detection rate for ESR1 mutations is higher in circulating-tumor-cell-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR.
Journal: Molecular oncology
Published: August 12, 2024
Direct comparison of an ultrasensitive real-time PCR assay with droplet digital PCR for the detection of PIK3CA hotspot mutations in primary tumors, plasma cell-free DNA and paired CTC-derived gDNAs.
Journal: Frontiers in oncology
Published: May 20, 2024
Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece.
Journal: Frontiers in pharmacology
Published: June 27, 2023
Prognostic significance of SOX17 and WNT5a promoter methylation status in circulating cell-free DNA metastatic colorectal cancer patients.
Journal: Hippokratia
Published: January 01, 2023
Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis.
Journal: Breast cancer research and treatment
Published: January 20, 2022
Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 "MELPOMENI" study).
Journal: Anticancer research
Published: November 29, 2021
MTHFR c.665C>T guided fluoropyrimidine therapy in cancer: gender-dependent effect on dose requirements.
Journal: Drug metabolism and personalized therapy
Published: November 19, 2021
Last Updated: 09/26/2026